athenahealth, Inc. (ATHN) Shares Sold by Gagnon Securities LLC
Gagnon Securities LLC decreased its stake in athenahealth, Inc. (NASDAQ:ATHN) by 51.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,906 shares of the health services provider’s stock after selling 32,287 shares during the period. athenahealth comprises about 1.4% of Gagnon Securities LLC’s investment portfolio, making the stock its 25th biggest position. Gagnon Securities LLC owned 0.07% of athenahealth worth $3,719,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently modified their holdings of the company. FMR LLC increased its holdings in shares of athenahealth by 0.8% in the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares during the last quarter. Janus Henderson Group PLC bought a new position in shares of athenahealth in the 2nd quarter worth $713,856,000. Vanguard Group Inc. increased its holdings in shares of athenahealth by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares during the last quarter. Capital Research Global Investors increased its holdings in shares of athenahealth by 15.5% in the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock worth $286,963,000 after buying an additional 273,660 shares during the last quarter. Finally, BlackRock Inc. increased its holdings in shares of athenahealth by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock worth $229,377,000 after buying an additional 32,146 shares during the last quarter.
In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the completion of the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $39,710,435.19. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Bradford Kyle Armbrester sold 1,000 shares of the stock in a transaction on Friday, October 27th. The shares were sold at an average price of $128.56, for a total transaction of $128,560.00. The disclosure for this sale can be found here. Insiders have sold a total of 9,283 shares of company stock valued at $1,175,908 in the last three months. 3.20% of the stock is currently owned by corporate insiders.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.60 EPS. equities research analysts expect that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.
A number of equities analysts have recently commented on the stock. Deutsche Bank assumed coverage on shares of athenahealth in a report on Friday. They issued a “hold” rating and a $145.00 price target on the stock. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, December 2nd. Cantor Fitzgerald reissued a “hold” rating and issued a $120.00 price target on shares of athenahealth in a report on Friday, October 27th. SunTrust Banks reissued a “buy” rating and issued a $156.00 price target on shares of athenahealth in a report on Wednesday, October 25th. Finally, Leerink Swann reduced their target price on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating on the stock in a report on Monday, October 23rd. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $143.29.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.